Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001181431-07-050084

Options or other derivatives

  • VP and Chief Medical Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Walicke Patricia A. · VP and Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2007-08-02 Grant or award : show line 1 in the form Option to Purchase Common Stock +200,000 200,000 D
Loading xslF345X02/rrd168148.xml…